Resting Heart Rate and Mortality: What 1.2 Million Participants Reveal

Why is resting heart rate an informative marker?

Resting heart rate reflects the state of the autonomic nervous system: the balance between sympathetic activation and parasympathetic tone, the level of cardiorespiratory fitness, chronic inflammation, and metabolic health. Unlike most biomarkers, resting heart rate requires no blood test and is accessible to everyone: in the morning, before getting out of bed, count your pulse for 60 seconds (or 30 seconds and multiply by two).

A comparison with classical risk factors is provided by Wen et al. in a large 2025 study (Progress in Cardiovascular Diseases; PMID: 39894380), which pooled data from the Taiwanese MJ cohort and the Norwegian HUNT cohort: 692,217 participants. A high resting heart rate (80–99 bpm) predicted mortality comparably to hypertension, and every +10 bpm was associated with roughly 3–4 fewer years of life expectancy.

What do the meta-analyses say?

The evidence base rests on several independent meta-analyses of large prospective cohorts.

Zhang et al., CMAJ 2016 (PMID: 26598376) — the most cited meta-analysis in this field: 46 prospective cohorts, 1,246,203 participants, 78,349 all-cause deaths. Per +10 bpm of resting heart rate: all-cause mortality RR=1.09 (95% CI: 1.07–1.12), cardiovascular mortality RR=1.08 (95% CI: 1.06–1.10).

Aune et al., Nutrition, Metabolism and Cardiovascular Diseases 2017 (PMID: 28552551) — broader scope: 87 prospective studies (48 on all-cause mortality). Per +10 bpm: all-cause mortality RR=1.17 (95% CI: 1.14–1.19), CVD — RR=1.15, heart failure — RR=1.18, stroke — RR=1.06, total cancer — RR=1.14.

Woodward et al., European Journal of Preventive Cardiology 2014 (PMID: 22718796) — analysis of 12 cohorts, 112,680 participants. Comparing extreme quartiles: resting heart rate 80 bpm and above vs. below 65 bpm — cardiovascular mortality HR=1.44 (95% CI: 1.29–1.60), all-cause mortality HR=1.54 (95% CI: 1.43–1.66), heart failure risk HR=2.08. Risk rises continuously starting from approximately 65 bpm.

The J-curve: why a very low pulse also signals risk

The relationship between resting heart rate and mortality is not linear — it follows a J-shaped curve. Both ends of the range are associated with elevated risk.

Cui et al., Clinical Research in Cardiology 2021 (PMC8166682) — uniquely long follow-up: 852 men, 48 years of follow-up. Reference zone — resting heart rate 60–70 bpm: lowest cardiovascular mortality. Below this zone: resting heart rate below 60 bpm — HR=1.41 (95% CI: 1.07–1.85; p=0.014). Above: resting heart rate 70–80 bpm — HR=1.34 (p=0.036); resting heart rate 90 bpm and above vs. 60–70 — all-cause mortality HR=1.60 (p=0.003).

Korean cohort 2024 (Journal of Sports Sciences, PMID: 39258733): 31,697 participants, 311 CVD deaths, 9.2 years of follow-up. J-curve confirmed: resting heart rate below 60 bpm — HR=1.48 (95% CI: 1.05–2.10); resting heart rate 80 bpm and above — HR=1.42 (95% CI: 1.06–1.91). Reference — 60–69 bpm.

An important caveat: in trained athletes, a resting heart rate of 40–55 bpm is a physiological norm — so-called athlete's bradycardia. It reflects high parasympathetic tone and structural cardiac adaptation. Pathological bradycardia — caused by sinus node dysfunction or heart block — is a separate clinical situation with different prognostic implications.

Chronically high heart rate is more dangerous than single measurements

A single resting heart rate measurement is just a snapshot. Prognostically more meaningful is the chronic burden of a high pulse and its trajectory over time.

Zhao et al., Scientific Reports 2017 (PMC5220288) — Kailuan cohort: 47,311 adults, median follow-up 4.06 years. Participants were assessed three times. Sustained resting heart rate of 80 bpm or above at all three measurements vs. never exceeding that threshold: HR=1.86 (95% CI: 1.33–2.61). J-shaped relationship confirmed.

Ristow et al., European Journal of Preventive Cardiology 2022 (Vol. 29(7):e249) — meta-analysis of heart rate change over time: 11 studies, 108,625 participants, mean interval between measurements 6.3 years. Rising resting heart rate over time: HR=1.21 (95% CI: 1.09–1.35; p<0.01). Heart rate trajectory is an independent predictor of mortality.

Chen et al., Open Heart 2026 (PMC13374445) — two representative US cohorts (NHANES 1999–2004, n=3,291; NHANES III, n=8,941). Per +10 bpm: all-cause mortality HR=1.26 (95% CI: 1.07–1.50) in the primary cohort. Notably: the association was detected as early as approximately age 30–35 — in young adults traditionally considered outside the cardiovascular risk window.

How to lower resting heart rate?

The most studied and reproducible tool is aerobic exercise.

Reimers et al., Journal of Clinical Medicine 2018 (PMC6306777) — meta-analysis of 191 studies, 12,952 participants. Aerobic training lowers resting heart rate by 2.7–5.8 bpm (4.5–9.0% from baseline). The optimal protocol: 30–40 minutes per session, 3–5 times per week. The pattern: the higher the baseline resting heart rate, the greater the reduction — meaning people with an initially high pulse gain the most from training.

For a long time it was believed that the reduction in resting heart rate from training was a consequence of increased vagal tone. D'Souza et al., Nature Communications 2014 (PMC4024745) revised this view. In animal experiments, aerobic training caused structural remodeling of the sinus node: reduced expression of HCN4 channels (funny channels) responsible for sinus node automaticity, and a roughly 47% decrease in I_f current density. The bradycardia persisted even after complete autonomic blockade — meaning this is not merely a nervous system adaptation, but a change in the pacemaker itself.

The practical takeaway: regular aerobic exercise remodels the heart at the level of ion channels, lowering its "factory rate." This is a reversible but long-term effect — when training stops, resting heart rate gradually returns to baseline.